Hypertension Secondary to COVID-19 Leading to Posterior Reversible Encephalopathy Syndrome in a 13-year-old Male
Journal of Clinical and Diagnostic Research
; 16(6):OD17-OD19, 2022.
Article
in English
| EMBASE | ID: covidwho-1918106
ABSTRACT
Posterior Reversible Encephalopathy Syndrome (PRES) is a clinico-radiological condition defined by white matter vasogenic oedema predominantly affecting the posterior occipital and parietal lobes. A 13-year-old male presented with complaints of fever for 4 days.Upon evaluation, he turned out positive for COVID-19 with a Computed Tomography (CT) severity score of 5/25. Three days post admission (day 7 of illness), patient developed sudden onset of painless, diminution of vision in both eyes followed by two episodes of generalised tonic clonic seizures. Examination revealed a blood pressure of 180/110 mmHg. Characteristic Magnetic Resonance Imaging (MRI) findings led to a diagnosis of PRES. Patient was treated with antiepileptics, antihypertensives and intravenous mannitol and made a complete recovery. Early identification, treatment of symptomatology and correction of the underlying cause are all key aspects of management.
adolescent; article; blood pressure; brain edema; case report; cerebral blindness; clinical article; computer assisted tomography; coronavirus disease 2019; drug combination; drug therapy; eye; fever; human; hypertension; intravenous drug administration; male; nuclear magnetic resonance imaging; posterior reversible encephalopathy syndrome; symptomatology; tonic clonic seizure; vision; anticonvulsive agent; antihypertensive agent; mannitol
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Journal of Clinical and Diagnostic Research
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS